期刊文献+

常用抗真菌药物的临床应用 被引量:2

暂未订购
导出
摘要 人类的真菌感染可累及表皮、皮下和全身。部分表皮真菌感染可以用局部抗真菌药物治疗和预防,有些则需要进行全身治疗;皮下和全身真菌感染采取口服和静脉给药治疗m。通过对常用抗真菌药研究状况的介绍为该项研究提供思路。
作者 任丽娟
机构地区 重庆市胸科医院
出处 《中国新医药》 2004年第2期63-64,共2页
  • 相关文献

参考文献5

二级参考文献61

  • 1冯胜昔,徐修容.治疗全身性真菌感染药物的研究进展[J].国外医学(药学分册),1993,20(4):234-237. 被引量:4
  • 2[11]Nesky MA, McDougal EC, Peacock Jr JE. Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage:case report and literature review of central nervous system pseudallescheriasis[J]. Clin Infect Dis, 2000, 31:673.
  • 3[12]Schwartz S, Milatovic D, Thiel E. Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia[J]. British J Haematol, 1997, 97: 663.
  • 4[13]Poza G, Montoya J, Redondo C, et al. Meningitis caused by Pseudallescheria boydii treated with voriconzole[J]. Clin Infect Dis, 2000, 30: 981 - 982.
  • 5[14]Louis G, Vant H, Paul E, et al. Successful treatment with voriconazole of invasion aspergillosis in chronic granulomatous disease[J]. Am J Respir Crit Care Medicine, 1998, 157: 1694.
  • 6[15]Jabado N, Casanova J, Haddad E, et al. Invasive pulmonary infection due to Scedosporium apiospermum in two children chronic granulomatous disease [J]. Clin Infect Dis, 1998, 27:1437.
  • 7[1]Dickinson RP, Bell AS, Hitchcock CA, et al. Novel antifungal 2 aryl 1-(1H-1, 2, 4-triazol 1-yl)butan-2-ol derivatives with high activity against aspergillus fumigatus [J]. Bioorgan Med Chem Lett, 1996, 65: 2031.
  • 8[2]Richardson K, Bell A, Dickinson R, et al. UK - 109,496, a nov el, wide-spectrum triazole derivative for the treatment of fungal infections: synthesis and SAR (abstract F69) [A]. Presented at the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy[C]. San Francisco: 1995, 9: 17.
  • 9[3]Sanati H, Belanger P, Fratti R, et al. A new triazole , voriconazole (UK- 109,496), blocks sterol biosynthesis in Candida albicans and Cadida krusei [J]. Antimicrob Agents Chemother,1997, 41: 2492.
  • 10[4]Hoban DJ, Zhanel GG, Karlowsky JK. In vitro susceptibities of candida and Cryptococcus neoformans isolates from blood cultures of neutropenic patients[J]. Antimicrob Agents Chemother,1999, 43(6): 1463 - 1464.

共引文献43

同被引文献14

  • 1曹永兵,张磊,王彦,姜远英.伏立康唑及其临床应用[J].中国新药与临床杂志,2005,24(4):330-332. 被引量:49
  • 2朱继业,冷希圣.肝移植术后真菌感染[J].临床外科杂志,2006,14(6):339-339. 被引量:3
  • 3侵袭性肺部真菌感染的诊断标准与治疗原则(草案)[J].中华内科杂志,2006,45(8):697-700. 被引量:879
  • 4中国侵袭性肺部真菌感染工作组.侵袭性肺部真菌感染的诊断标准与治疗原则(草案).待发表.
  • 5Maertens J,Van Eldere J,Verhaegen P,et al.Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients[J].J Infect Dis,2002,186:1297-1306.
  • 6Becker MJ,Lugtenburg E J,Cornelissen JJ,et al.Galactomannan detection in computerized tomographybased broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis[J].Br J Haematol,2003,121:448-457.
  • 7Reichenberger F,Habicht JM,Gratwohl A,et al.Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients[J].Eur Respir J,2002,19 (4):743-755.
  • 8Talemoto K,Yamanoto Y,Ueda Y,et al.Comparative studies on the efficacy of amBisome and fungizone in a mouse model of disseminated aspergillosis[J].J Animicrob Chemother,2004,53(2):311-317.
  • 9Caillot D.Intravenous itraconazole followed by oral itraconazole for the treatment of amphotericin-B-refractory invasive pulmonary aspergillosis[J].Acta Haematol,2003,109 (3):111-118.
  • 10Walsh TJ,Papps P,Winston DJ,et al.Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropeinia and persistent fever[J].N Engl J Med,2002,346 (4):225-234.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部